Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis.

[1]  Pitchai Balakumar,et al.  Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats. , 2014, Pharmacological research.

[2]  K. Sinha,et al.  Mangiferin Attenuates Diabetic Nephropathy by Inhibiting Oxidative Stress Mediated Signaling Cascade, TNFα Related and Mitochondrial Dependent Apoptotic Pathways in Streptozotocin-Induced Diabetic Rats , 2014, PloS one.

[3]  M. M. Al-Gayyar,et al.  Chemopreventive and hepatoprotective effects of Epigallocatechin‐gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway , 2014, The Journal of pharmacy and pharmacology.

[4]  U. Singh,et al.  Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. , 2014, Current drug targets.

[5]  Shuyi Cao,et al.  Emodin Suppresses Hyperglycemia-Induced Proliferation and Fibronectin Expression in Mesangial Cells via Inhibiting cFLIP , 2014, PloS one.

[6]  P. Balakumar,et al.  Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats. , 2014, International journal of cardiology.

[7]  Xiuli Zhang,et al.  Zinc Modulates High Glucose-Induced Apoptosis by Suppressing Oxidative Stress in Renal Tubular Epithelial Cells , 2014, Biological Trace Element Research.

[8]  J. Klawitter,et al.  CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  Yang Zhang,et al.  Establishment of an Inflamed Animal Model of Diabetic Nephropathy , 2014, International journal of biological sciences.

[10]  Lan-yu Zhang,et al.  High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-?B/NADPH oxidase/ROS pathway, which is inhibited by resveratrol , 2013 .

[11]  A. Mima.  Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets , 2013, Journal of diabetes research.

[12]  A. Avogaro,et al.  Achieving glycemic control in patients with type 2 diabetes and renal impairment , 2013, Acta Diabetologica.

[13]  N. Elsherbiny,et al.  Adenosine receptors: new therapeutic targets for inflammation in diabetic nephropathy. , 2013, Inflammation & allergy drug targets.

[14]  B. Cronstein,et al.  Regulation of Inflammation by Adenosine , 2013, Front. Immunol..

[15]  K. H. Abd El Galil,et al.  Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1. , 2012, European cytokine network.

[16]  Xiaokun Li,et al.  Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats , 2012, British journal of pharmacology.

[17]  J. Zou,et al.  High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. , 2012, The international journal of biochemistry & cell biology.

[18]  JoelLinden.  Role of Adenosine in Response to Vascular Inflammation , 2012 .

[19]  Koichi Matsumoto,et al.  Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications , 2012, Acta Diabetologica.

[20]  J. G. van der Hoeven,et al.  Dipyridamole augments the antiinflammatory response during human endotoxemia , 2011, Critical care.

[21]  Katarina S. Persson,et al.  Activation of Adenosine A2A Receptors Inhibits Neutrophil Transuroepithelial Migration , 2011, Infection and Immunity.

[22]  M. Soliman.  Nucleoside transport inhibitor, dipyridamole, induced myocardial protection following hemorrhagic shock in ex vivo perfused rat hearts. , 2011, Journal of the Saudi Heart Association.

[23]  L. Thompson,et al.  Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology , 2010, Journal of Immunology.

[24]  T. Nakano,et al.  Adenosine-induced caspase-3 activation by tuning Bcl-XL/DIABLO/IAP expression in HuH-7 human hepatoma cells , 2010, Cell Biology and Toxicology.

[25]  Changlin Mei,et al.  Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells. , 2009, American journal of physiology. Renal physiology.

[26]  D. Dekker,et al.  The role of reactive oxygen species in apoptosis of the diabetic kidney , 2009, Apoptosis.

[27]  Hung-Jung Lin,et al.  The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells. , 2009, Biochemical and biophysical research communications.

[28]  K. Chopra,et al.  Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. , 2009, Life sciences.

[29]  K. Demır,et al.  A new agent for tumour necrosis factor-alpha inhibition , 2009, Scandinavian journal of clinical and laboratory investigation.

[30]  Y. Khalifa,et al.  Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. , 2008, Investigative ophthalmology & visual science.

[31]  M. Kawamata,et al.  Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A1 receptors in isolated rat diaphragms , 2008, Acta anaesthesiologica Scandinavica.

[32]  A. Fornoni,et al.  Role of inflammation in diabetic nephropathy. , 2008, Current diabetes reviews.

[33]  Hideyuki Yamamoto,et al.  Intracellularly transported adenosine induces apoptosis in HuH-7 human hepatoma cells by downregulating c-FLIP expression causing caspase-3/-8 activation. , 2007, Biochemical pharmacology.

[34]  Ling-Fei Wu,et al.  Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells , 2006, Acta Pharmacologica Sinica.

[35]  L. Singh,et al.  An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells , 2006, Archives of physiology and biochemistry.

[36]  S. Colgan,et al.  HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia , 2005, The Journal of experimental medicine.

[37]  H. Kusaka,et al.  Adenosine uptake inhibitors. , 2004, European journal of pharmacology.

[38]  C. Dalmaz,et al.  Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats. , 2003, European journal of pharmacology.

[39]  F. Vargas,et al.  Antioxidant properties of dipyridamole as assessed by chemiluminescence. , 2003, Die Pharmazie.

[40]  H. Ha,et al.  Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[41]  A. Kessler,et al.  High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. , 2003, American journal of physiology. Renal physiology.

[42]  M. Chello,et al.  Inhibition by dipyridamole of neutrophil adhesion to vascular endothelium during coronary bypass surgery. , 1999, The Annals of thoracic surgery.

[43]  M. Girndt,et al.  Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. , 1995, Kidney international.

[44]  K. Onodera,et al.  Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice. , 1994, Methods and findings in experimental and clinical pharmacology.

[45]  L. Howell,et al.  Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey. , 1993, The Journal of pharmacology and experimental therapeutics.

[46]  S. Sakuta,et al.  Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[47]  L. Mcphail,et al.  Superoxide dismutase activity in leukocytes. , 1974, The Journal of clinical investigation.

[48]  E. Picano,et al.  Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients. , 2013, Clinical laboratory.

[49]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[50]  R. Rabkin.  Diabetic nephropathy. , 2003, Clinical cornerstone.

[51]  H. Kusaka,et al.  KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice. , 2002, The Journal of pharmacology and experimental therapeutics.